Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI
I think it will overall benefit the health system with reducing costs related to obesity treatment, cardiovascular disease, said Dana Small, a neurology and neurosurgery professor at McGill University, according to a report from Global News
Hormonal changes during perimenopause may contribute to metabolic alterations, though weight gain is multifactorial and not solely attributable to hormonal shifts
Tirzepatide is one of the newest and most effective options for medical weight loss, helping patients lose weight faster and more consistently than ever before
